BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 24789421)

  • 41. Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.
    Tsurutani J; Sakata Y; Matsuoka T
    Breast Cancer; 2019 Mar; 26(2):235-243. PubMed ID: 30324551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
    Jin L; Zhang Y; Yang W
    Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.
    Alberti P; Rossi E; Cornblath DR; Merkies IS; Postma TJ; Frigeni B; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Faber CG; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Valsecchi MG; Cavaletti G;
    Ann Oncol; 2014 Jan; 25(1):257-64. PubMed ID: 24256846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN).
    Hertz DL; Childs DS; Park SB; Faithfull S; Ke Y; Ali NT; McGlown SM; Chan A; Grech LB; Loprinzi CL; Ruddy KJ; Lustberg M
    Cancer Treat Rev; 2021 Sep; 99():102241. PubMed ID: 34174668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN.
    Zahiri M; Chen KM; Zhou H; Nguyen H; Workeneh BT; Yellapragada SV; Sada YH; Schwenk M; Najafi B
    J Geriatr Oncol; 2019 Nov; 10(6):960-967. PubMed ID: 30665876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.
    Postma TJ; Aaronson NK; Heimans JJ; Muller MJ; Hildebrand JG; Delattre JY; Hoang-Xuan K; Lantéri-Minet M; Grant R; Huddart R; Moynihan C; Maher J; Lucey R;
    Eur J Cancer; 2005 May; 41(8):1135-9. PubMed ID: 15911236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life.
    Eikeland SA; Smeland KB; Mols F; Fagerli UM; Bersvendsen HS; Kiserud CE; Fosså A
    Acta Oncol; 2021 Jul; 60(7):911-920. PubMed ID: 33905285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.
    McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB
    Support Care Cancer; 2019 Oct; 27(10):3849-3857. PubMed ID: 30756229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes.
    Zhi WI; Baser RE; Zhi LM; Talukder D; Li QS; Paul T; Patterson C; Piulson L; Seluzicki C; Galantino ML; Bao T
    Cancer Med; 2021 Aug; 10(16):5456-5465. PubMed ID: 34213086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches.
    Knoerl R; Smith EML; Han A; Doe A; Scott K; Berry DL
    Patient Educ Couns; 2019 Sep; 102(9):1636-1643. PubMed ID: 31003878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
    Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS
    Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.
    Loprinzi CL; Lacchetti C; Bleeker J; Cavaletti G; Chauhan C; Hertz DL; Kelley MR; Lavino A; Lustberg MB; Paice JA; Schneider BP; Lavoie Smith EM; Smith ML; Smith TJ; Wagner-Johnston N; Hershman DL
    J Clin Oncol; 2020 Oct; 38(28):3325-3348. PubMed ID: 32663120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
    Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R
    BMC Cancer; 2019 Feb; 19(1):132. PubMed ID: 30736741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
    Hou S; Huh B; Kim HK; Kim KH; Abdi S
    Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.
    Mols F; Beijers AJ; Vreugdenhil G; Verhulst A; Schep G; Husson O
    J Cancer Surviv; 2015 Sep; 9(3):512-22. PubMed ID: 25876556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
    Kurt S; Can G
    Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time.
    Wang M; Cheng HL; Lopez V; Sundar R; Yorke J; Molassiotis A
    BMC Cancer; 2019 Nov; 19(1):1151. PubMed ID: 31775665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effectiveness of Non-Pharmacologic Interventions in Chemotherapy Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis].
    Oh PJ; Kim YL
    J Korean Acad Nurs; 2018 Apr; 48(2):123-142. PubMed ID: 29735874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.
    Al-Atiyyat N; Obaid A
    Int J Palliat Nurs; 2017 Jan; 23(1):13-17. PubMed ID: 28132604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties.
    Griffith KA; Merkies IS; Hill EE; Cornblath DR
    J Peripher Nerv Syst; 2010 Dec; 15(4):314-25. PubMed ID: 21199103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.